Behavioral HealthNews
Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs
National Institute of Mental Health | September 15, 2026
The overarching goal of this concept is to encourage research that aims to better understand the real-world effectiveness of rapid-acting psychotropic interventional drugs (RAPIDs) in heterogenous patient populations and generate the actionable evidence needed by healthcare systems to guide broad clinical implementation. Read More
Source: National Institute of Mental HealthSource: National Institute of Mental Health
Recent Posts
Apogem Capital Leads Minority Investment in Family Care Center
Laura Lovett | October 21, 2026
Do Psychedelics Need a Rebrand Before Their Approval for Mental Health?
Ashleigh Hollowell | October 21, 2026
Virginia mental health provider to settle Medicaid billing allegations for $1.8M
Ella Ruder | October 21, 2026
Covenant Health taps behavioral health VP
Ella Ruder | October 21, 2026
Ketamine drugmakers seek FDA approval as providers raise concerns: 5 things to know
Ella Ruder | October 21, 2026
Integrated Psychiatric Consultants
Office Hours:Mon-Fri, 9 a.m. - 5 p.m. CT